Exclusive: Ex-Recursion team launches Leash Bio, challenging AI field with its bet on needing more data
04 Apr 2024
For all the high-flying claims for AI in drug discovery, Leash Bio has started with a more grounded approach — literally.
Leash’s lab and headquarters were in the basement of Ian Quigley’s Utah home for the company’s first two years. The startup recently moved to its first proper office in a Salt Lake City incubator, and it’s now publicly launching with a challenge to the AI bio-industry: You’re going to need way, way more data.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.